A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia

NCT03692052 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Agios Pharmaceuticals, Inc.